Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ziad A Ali Added: 7 months ago
ESC 2023 — Dr Ziad Ali (DeMatteis St Francis, US) joins us to discuss the findings from the ILUMIEN IV clinical trial (NCT03507777). ILUMIEN IV (Abbott Medical Devices)is a prospective, single-blind clinical trial aiming to compare optical coherence tomography (OCT) to an angiography-guided stent implantation strategy. The trial investigated which method achieved a larger post-percutaneous… View more
Author(s): Anouar Belkacemi , Pierfrancesco Agostoni , Michiel Voskuil , et al Added: 3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug… View more
Author(s): Peter Barlis , Mun Hong Cheang , Carlo Di Mario Added: 3 years ago
In the past few decades, tremendous developments have been made in the field of interventional cardiology. The evolution of such tools as balloon angioplasty, bare-metal stents (BMS) and now drug-eluting stents (DES) has incrementally opened up new possibilities in the treatment of coronary artery disease and, correspondingly, an ever-decreasing need for invasive surgery. The most challenging… View more
Author(s): Marjan Jahangiri , Krishna Mani , Martin T Yates , et al Added: 3 years ago
With evolving stent technology, improvements in percutaneous coronary intervention (PCI) techniques and the use of antithrombotic medications, the role of PCI in the treatment of left main stem (LMS) disease has expanded from being confined to salvage scenarios to intermediate- and lower-risk patients. However, the role and benefits of coronary artery bypass grafting (CABG) surgery in the… View more
Author(s): Joo-Yong Hahn Added: 1 year ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions … View more
Author(s): Niels Ramsing Holm Added: 7 months ago
ESC 2023 — Dr Niels Ramsing Holm (Aarhus University, DK) outlines the findings from the OCTOBER trial (NCT03171311). The OCTOBER trial (Aarhus University Hospital Skejby, Abbott) aimed to compare the median two-year clinical outcome after optical coherence tomography (OCT) guided percutaneous coronary intervention (PCI) as compared to angiographic-guided PCI. This was an investigator-initiated… View more
Author(s): Robert Gil , Tomasz Pawlowski Added: 2 years ago
Philips, in collaboration with Radcliffe Cardiology, are pleased to present expert video cases filmed at the Central Clinical Hospital of the MSWiA, Warsaw, Poland. In these videos, Prof Robert Giland Dr Tomasz Pawlowskiperform three cases, incorporating the treatment of OM-CX with bifurcation - dedicated stent, Bifurcation stenting and Complex PCI in distal LM stenosis. Further references… View more
Author(s): Thierry Lefèvre , Yves Louvard , Marie-Claude Morice Added: 3 years ago
Coronary bifurcation lesions with involvement of a significant side branch are a frequent occurrence. The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study showed that systematic use of drug-eluting stents (DES) resulted in an increase from 8% to 16% in the number of bifurcation lesions being stented over a one-year period. 1 This high incidence of coronary… View more
Author(s): Thierry Lefèvre , Yves Louvard , Marie-Claude Morice Added: 3 years ago
Coronary bifurcation lesions with involvement of a significant side branch are a frequent occurrence. The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study showed that systematic use of drug-eluting stents (DES) resulted in an increase from 8% to 16% in the number of bifurcation lesions being stented over a one-year period. 1 This high incidence of coronary… View more